US Patent Issued to The Administrators of the Tulane Educational Fund on Sept. 15 for "CRISPR-based assay for detecting TB in bodily fluids" (Louisiana Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,735,753, issued on Sept. 15, was assigned to The Administrators of the Tulane Educational Fund (New Orleans).

"CRISPR-based assay for detecting TB in bodily fluids" was invented by Tony Ye Hu (New Orleans), Bo Ning (New Orleans) and Zhen Huang (New Orleans).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure describes a method for detecting the presence of Mycobacterium tuberculosis in a bodily fluid sample. The method utilizes CRISPR effector proteins along with a guide RNA and a reporter molecule, such that when the guide RNA hybridizes with a target nucleotide fragment, the CRISPR effector protein cleaves the reporter molecule, resu...